Gene · 7376
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro. | Int J Mol Sci | 2023 | 36835055 | PubTator, text mining | PubMed |
| Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells. | Biomolecules | 2023 | 36830714 | PubTator, text mining | PubMed |
| Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases. | Front Med (Lausanne) | 2023 | 36817797 | PubTator, text mining | PubMed |
| Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders. | ACS Omega | 2023 | 36816679 | PubTator, text mining | PubMed |
| Sex Significantly Impacts the Function of Major Depression-Linked Variants In Vivo. | Biol Psychiatry | 2023 | 36803612 | PubTator, text mining | PubMed |
| Liver X receptor controls follicular helper T cell differentiation via repression of TCF-1. | Proc Natl Acad Sci U S A | 2023 | 36802434 | PubTator, text mining | PubMed |
| Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses. | Cell Death Dis | 2023 | 36792589 | PubTator, text mining | PubMed |
| Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line. | Molecules | 2023 | 36770927 | PubTator, text mining | PubMed |
| Novel 1,4-Dihydropyridine Derivatives as Mineralocorticoid Receptor Antagonists. | Int J Mol Sci | 2023 | 36768761 | PubTator, text mining | PubMed |
| Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2-a]pyridine Structure. | J Med Chem | 2023 | 36756805 | PubTator, text mining | PubMed |
| Metabolic reprogramming in colorectal cancer: regulatory networks and therapy. | Cell Biosci | 2023 | 36755301 | PubTator, text mining | PubMed |
| Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer's disease. | Chin Med | 2023 | 36747236 | PubTator, text mining | PubMed |
| In silico molecular modeling and simulations of black tea theaflavins revealed theaflavin-3'-gallate as putative liver X receptor-beta agonist. | J Biomol Struct Dyn | 2023 | 36729100 | PubTator, text mining | PubMed |
| Neuropathic pain: Mechanisms and therapeutic strategies. | Front Cell Dev Biol | 2023 | 36727110 | PubTator, text mining | PubMed |
| Exploring the hub mechanisms of ischemic stroke based on protein-protein interaction networks related to ischemic stroke and inflammatory bowel disease. | Sci Rep | 2023 | 36720935 | PubTator, text mining | PubMed |
| Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway. | Cell Death Dis | 2023 | 36681687 | PubTator, text mining | PubMed |
| Host Genetic Variants Linked to COVID-19 Neurological Complications and Susceptibility in Young Adults-A Preliminary Analysis. | J Pers Med | 2023 | 36675784 | PubTator, text mining | PubMed |
| Molecular Landscape of Tourette's Disorder. | Int J Mol Sci | 2023 | 36674940 | PubTator, text mining | PubMed |
| Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases. | Int J Mol Sci | 2023 | 36674804 | PubTator, text mining | PubMed |
| Structures of human TR4LBD-JAZF1 and TR4DBD-DNA complexes reveal the molecular basis of transcriptional regulation. | Nucleic Acids Res | 2023 | 36651297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7376/papers?page=11